Showing results (531-540 of 569) with videos related to
Sort By:
Pageof 57
JACC. Cardiovascular Imaging|December 19, 2021
CAC for Risk Stratification Among Individuals With Hypertriglyceridemia Free of Clinical Atherosclerotic Cardiovascular DiseaseMiguel Cainzos-Achirica, Renato Quispe, Ramzi Dudum, et al.European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomasPhilipp Jansen, Wolfgang Galetzka, Georg C Lodde, et al.Trials|October 31, 2025
SaVeBRAIN.Kids-study protocol for a cluster-randomized stepped-wedge trial to reduce hospitalizations for mild traumatic brain injury in children in GermanyNora Bruns, Pia Brensing, Linda von der Heiden, et al.Antimicrobial Agents and Chemotherapy|November 30, 2011
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 studyKimberly A Porter, Stephen R Cole, Joseph J Eron, et al.Environmental Health Perspectives|February 9, 2002
Assessing exposure in epidemiologic studies to disinfection by-products in drinking water: report from an international workshopTye E Arbuckle, Steve E Hrudey, Stuart W Krasner, et al.Journal of the American Heart Association|August 9, 2022
Coronary Artery Calcium Score to Refine the Use of PCSK9i in Asymptomatic Individuals: A Multicohort StudyMiguel Cainzos-Achirica, Renato Quispe, Reed Mszar, et al.European Journal of Cancer (Oxford, England : 1990)|July 24, 2023
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) studyGeorg C Lodde, Jessica Hassel, Lena M Wulfken, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2025
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III MelanomaGeorg C Lodde, Jessica C Hassel, Imke von Wasielewski, et al.Scientific Reports|December 18, 2025
Epidemiology and treatment of malignant ovarian germ cell and sex cord stromal tumors in germany: a population-based cancer registry study from 2016 - 2021Dennis Jung, Sinaida Branscheidt, Ian Wittenberg, et al.Journal for Immunotherapy of Cancer|May 7, 2020
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOGSarah Knispel, Andreas Stang, Lisa Zimmer, et al.Pageof 57